J. David Hansen
2015
In 2015, J. David Hansen earned a total compensation of $4.2M as President, Chief Executive Officer and Chairman at MabVax Therapeutics Holdings, a 1,021% increase compared to previous year.
Compensation breakdown
| Bonus | $149,625 |
|---|---|
| Option Awards | $1,493,194 |
| Salary | $375,601 |
| Stock Awards | $2,077,475 |
| Other | $87,770 |
| Total | $4,183,665 |
Hansen received $2.1M in stock awards, accounting for 50% of the total pay in 2015.
Hansen also received $149.6K in bonus, $1.5M in option awards, $375.6K in salary and $87.8K in other compensation.
Rankings
In 2015, J. David Hansen's compensation ranked 2,060th out of 13,638 executives tracked by ExecPay. In other words, Hansen earned more than 84.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,060 out of 13,638 | 85th |
Division Manufacturing | 736 out of 5,190 | 86th |
Major group Chemicals And Allied Products | 266 out of 1,854 | 86th |
Industry group Drugs | 209 out of 1,528 | 86th |
Industry Pharmaceutical Preparations | 167 out of 1,182 | 86th |
Source: SEC filing on May 2, 2017.
Hansen's colleagues
We found three more compensation records of executives who worked with J. David Hansen at MabVax Therapeutics Holdings in 2015.